Table 2.
DOX | AD198 | |
---|---|---|
K9TCC#2-Dakota | 0.85 μM | 0.42 μM |
K9TCC#1-Lillie | 0.83 μM | 0.56 μM |
K9TCC#4-Molly | 2.07 μM | 0.75 μM |
K9OSA#1-Zoe | 1.36 μM | 0.77 μM |
K9OSA#2-Nashville | 0.88 μM | 0.66 μM |
K9OSA#3-JJ | 2.22 μM | 1.13 μM |
Note: IC50 values of DOX and AD198 of tested K9TCC and K9OSA cell lines were calculated from cell proliferation data obtained from 0.1, 0.5, 1 μM treatments with DOX and AD198 for 48 hours.
Abbreviations: DOX, doxorubicin; K9OSA, canine osteosarcoma; K9TCC, canine transitional cell carcinoma.